stem cells
Blood-Based MRD Testing Identifies AML Patients at Risk of Relapse After Stem Cell Transplant
Researchers looked at AML variants in the blood of patients prior to their allogeneic hematopoietic cell transplant and correlated them with subsequent relapse or death.
CareDx Receives CE Mark for Hematopoietic Cell Transplantation Testing Kit, Analysis Software
The designation furthers the firm's expansion into the stem cell transplant space, which began with the launch of AlloCell in 2020.
Avrobio, Saladax Biomedical Partner on Busulfan Monitoring Assay
Busulfan is a chemotherapeutic used as conditioning agent prior to hematopoietic stem cell transplants, which are used in Avrobio's investigational therapies.